TRCT
PMC

Tower Research Capital (TRC)’s PharMerica Corporation PMC Stock Holding History

Tower Research Capital (TRC)’s Portfolio PMC Stock Details PMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1,032
Closed -$26K – 4481
2016
Q4 		$26K Buy
1,032
+962
+1,374% +$24.3K ﹤0.01% 1927
2016
Q3 		$2K Buy
+70
New +$1.79K ﹤0.01% 3212
2016
Q1 		– Sell
-100
Closed -$4K – 5472
2015
Q4 		$4K Sell
100
-639
-86% -$20K ﹤0.01% 3338
2015
Q3 		$21K Sell
739
-1,861
-72% -$62.5K ﹤0.01% 1705
2015
Q2 		$87K Sell
2,600
-2,817
-52% -$86.5K 0.01% 960
2015
Q1 		$153K Buy
5,417
+5,267
+3,511% +$131K 0.02% 576
2014
Q4 		$3K Sell
150
-6,342
-98% -$151K ﹤0.01% 3220
2014
Q3 		$159K Buy
+6,492
New +$172K 0.02% 628
2014
Q2 		– Sell
-6,255
Closed -$175K – 5015
2014
Q1 		$175K Buy
6,255
+5,099
+441% +$125K 0.02% 455
2013
Q4 		$25K Sell
1,156
-5,831
-83% -$106K ﹤0.01% 2098
2013
Q3 		$93K Buy
6,987
+6,591
+1,664% +$88.8K 0.01% 1368
2013
Q2 		$5K Buy
+396
New +$5.61K ﹤0.01% 3001

Other funds holding PMC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DGI
Discovery Group I Chicago, Illinois $262M AUM 29.24% 1-Year Est. Return

Tower Research Capital (TRC)'s PMC Position: Q1 2017 in Review

Tower Research Capital (TRC) sold out of PharMerica Corporation (PMC) in Q1 2017, closing a stake of 1,032 shares — an estimated $26K sold.

Tower Research Capital (TRC) first reported a position in PMC in Q2 2013 and held it in 12 quarters. The position peaked at $175K in Q1 2014. 152 funds tracked by Wall St. Rank hold PMC as of Q1 2017.

  • Tower Research Capital (TRC) reported no remaining PharMerica Corporation position as of Q1 2017 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 1,032 PharMerica Corporation shares in Q1 2017, an estimated $26K.
  • Tower Research Capital (TRC) first reported a position in PharMerica Corporation in Q2 2013 and held it in 12 quarters.
  • Tower Research Capital (TRC)'s PharMerica Corporation position peaked at $175K in Q1 2014.
  • 152 funds tracked by Wall St. Rank held PharMerica Corporation as of Q1 2017.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2017, filed 19 May 2017.